Sectra: HIT supplier for UK initiative, deploys PACS to three Norwegian hospitals

Swedish IT and medical technology company Sectra Imtec AB has signed a 10-year contract with Philips Medical Systems Nederland B.V. for delivery of its PACS software for the London cluster of the National Health Service's (NHS) National Programme for Information Technology (NPfIT).
   
The National Programme for IT is being implemented in five regional clusters, Sectra said. The London cluster comprises the NHS hospitals in the London region. Sectra will be subcontracting its software to Philips for deliveries of PACS to this region under a separate agreement between BT, the designated local service provider for the London cluster, and Philips Medical Systems.
   
The contract is part of a major government initiative to dramatically increase the level of investments in IT within the NHS, Sectra said.
   
In related company news, Sectra announced that it signed a $1 million contract with SØrlandet Sykehus HF in Norway for the installation of Sectra's system for handling and archiving of digital radiology images (PACS) at three hospitals in the county of Vest-Agder.
   
The hospitals in Kristiansand, Mandal and Flekke fjord will be installing Sectra PACS. The order represents an expansion of Sectra's existing agreement, under which Arendal Hospital in the county of Aust-Agder is already using the same system.
    
Installation of the new system will begin next month.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.